The Pan-Canadian Collaboration for Quality Assurance in Radiopharmaceutical Therapy (PCQRT) underscore crucial elements of radiopharmaceutical therapy quality assurance that should be consistent across all Radiopharmaceutical Therapy programs in Canada. They do not aim to supplant detailed specifications, standard operational procedures, or institution-specific policies. Instead, their purpose is to support the formation and preservation of a national approach to radiopharmaceutical therapy quality assurance.
The paramount goal is to ensure that Canadians receive radiopharmaceutical therapy of the highest caliber, seamlessly integrated into the broader landscape of cancer care, while actively mitigating the risks associated with medical errors and undesired clinical results. Implementation and ongoing monitoring of quality assurance measures should be embraced by all organizations and agencies devoted to radiopharmaceutical cancer treatment within the country.
